File(s) under permanent embargo
AMPA receptor potentiators
standard
posted on 2023-06-09, 19:06 authored by Simon Ward, Paul Beswick, Lewis Pennicott, Tristan ReuillonThe invention provides compounds of the formula (I): wherein R1 and R2 are defined in the specification, to pharmaceutical compositions comprising the compounds and the compounds for use as medicaments. The compounds potentiate AMPA receptor function and are expected to be useful in the treatment of central nervous system disorders, for example in the treatment of depressive disorders, mood disorders and cognitive dysfunction associated with neuropsychiatric disorders such as schizophrenia
History
Publication status
- Published
File Version
- Published version
Pages
58.0Patent number
WO2018146486Department affiliated with
- Chemistry Publications
Research groups affiliated with
- Sussex Drug Discovery Centre Publications
Full text available
- No
Legacy Posted Date
2019-10-01First Compliant Deposit (FCD) Date
2019-10-01Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC